HYCAMTIN subst sèche 4 mg flac

7680538570270 CH-53857 L01XX17 07.16.1.

Reimbursement limitations:

HYCAMTIN

Traitement de deuxième ligne du cancer bronchique à petites cellules en cas d'échec ou de …

HYCAMTIN subst sèche 4 mg flac
HYCAMTIN subst sèche 4 mg flac
HYCAMTIN subst sèche 4 mg flac
1 / 3
google

Details

Product number
5385701
CPT
-
Packaging group
1
Unit
Durchstechflasche(n)
Composition
Praeparatio sicca: topotecanum 4 mg ut topotecani hydrochloridum, acidum tartaricum, mannitolum, acidum hydrochloridum aut natrii hydroxidum, pro vitro corresp. natrium 1.68 mg.

Articles (1)

Hycamtin 4 mg, Lyophilisat
Lyophilisat
1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
29/07/2022
Professional SmPC
Français
29/07/2022
Professional SmPC
Italien
29/07/2022

Detailed composition

Substance Quantity Type Category
PRS
4.0 MG Substance Wirkstoff (Principe actif)
PRS
- Substance WIZUS
PRS
- Substance HNIDK
PRS
- Substance HNIDK
PRS
- Substance HNIDK
PRS
- Substance HNIDK
PRS
1.68 MG Substance HBESI

Reimbursement information

Public price
CHF 308.25
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 15/03/1998

Authorization holder

Sandoz Pharmaceuticals AG

6343 Risch

Authorization information

Swissmedic authorization number
53857
Drug name
Hycamtin, Lyophilisat
Galenic form
PULPA
ATC Code
L01XX17
Authorization status
Z
Dispensation category
A
First authorization
16/10/1996
Authorization expiration date
31/12/9999
IT number
07.16.1.
Domain
Human medicine
Field of application
Ovarialkarzinom, kleinzelliges Bronchialkarzinom, Zervixkarzinom

Packaging details

Description (FR)
HYCAMTIN subst sèche 4 mg flac
Description (DE)
HYCAMTIN Trockensub 4 mg Durchstf
Market launch
16/10/1996
Narcotic (BTM)
No

Other packaging sizes

HYCAMTIN subst sèche 4 mg flac 5 pce
5 DUR
View
HYCAMTIN subst sèche 1 mg flac
1 DUR
View